May 22 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified a recall of Hologic's devices that are implanted in soft tissue such as breast tissue as "most serious." (Reporting by Mariam Sunny in Bengaluru; Editing by Shailesh Kuber)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.79 USD | -0.49% | -3.65% | +0.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.48% | 16.75B | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+14.48% | 52.6B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- FDA classifies recall of Hologic's implants for soft tissue as 'most serious'